THE ROLE OF RESPIRATORY VIRUSES IN ACUTE AND CHRONIC ASTHMA

Abstract

Respiratory tract infections caused by viruses, 24, 70 chlamydia, 18, 19, 43, 55, 116 and mycoplasma⁶¹ have been implicated in the pathogenesis of asthma. Viruses have been demonstrated to be associated with asthma epidemiologically in at least two ways (Fig. 1). First, during infancy, certain viruses have been implicated as potentially being responsible for the inception of the asthmatic phenotype. Second, in patients, particularly children, with established asthma, viral upper respiratory tract infections play a significant role in producing acute exacerbations of airway obstruction that may result in frequent outpatient visits or hospitalizations. 24, 55, 56, 57 This article reviews these two areas by focusing first on mechanisms by which virus infections may lead to the development of asthma in infants and children and, second, on mechanisms by which virus infections may produce acute asthmatic symptoms in patients who already have established disease.

VIRAL INFECTIONS AND THE INCEPTION OF ASTHMA

Infections with respiratory syncytial virus (RSV) or parainfluenza virus (PIV) have received much attention because of their predilection to produce a pattern of symptoms termed bronchiolitis that parallels many of the features of childhood and adult asthma.⁶⁷ Respiratory syncytial virus causes about 70% of these episodes and it is estimated that, by age 1 year, 50% to 65% of children will have been infected with this virus⁷⁷ and 40% of these infections involve the lower respiratory tract.⁹² By age 2, nearly all children will have been infected with RSV at least once. Children aged 3 to 6 months are most prone to develop lower respiratory tract symptoms, suggesting that a developmental component (e.g., lung or immunologic maturation) may be involved as well. 77, 83

Figure 1.

Mechanisms by which viruses may influence either the inception of asthma or exacerbations of the underlying disease process once it has been established. RSV = respiratory syncytial virus; PIV = parainfluenza virus.

The relationship between RSV infections during the first few years of life and the subsequent development of the asthmatic phenotype has been the subject of much interest as well as controversy. Variations in reporting longitudinal outcomes (e.g., recurrent wheezing, measurements of airway hyperresponsiveness, diagnosis of asthma) appear to be influenced mostly by the criteria used to define “bronchiolitis.” These criteria include the type of virus producing the symptoms (in addition to RSV, viruses that may contribute to the development of bronchiolitis in this age group could be PIV, coronavirus, influenzavirus, and rhinovirus³³); the age at the time of infection; the nature and severity of symptoms required for inclusion; and, finally, the characteristics of both the study population (community versus hospital-based) and the study design (retrospective versus prospective). A number of long-term prospective studies of children admitted to a hospital with documented RSV-induced bronchiolitis have shown that about 75% experience wheezing in the first 2 years after the initial illness, more than 50% still wheeze 3 years later, and approximately 40% continue to wheeze after 5 years. 42, 49, 73, 91, 117, 121

Additional insight into these areas recently was provided by the results of an 11-year prospective study involving 880 children who were enrolled at birth, followed for the development of lower respiratory tract illnesses (LRIs) in the first 3 years of life, and then evaluated for the presence or absence of physician-diagnosed asthma or a history of current wheezing at ages 6 and 11 years.¹⁴ Most importantly, lung function was evaluated in the first few months of life in a subset of these children prior to the development of a documented LRI. During the first 3 years of life, 7.4% had pneumonia documented radiographically and 44.7% had a significant LRI without pneumonia. Respiratory syncytial virus and PIV were identified in 36.4% and 7.3%, respectively, in the subjects with pneumonia, and in 35.6% and 15.2%, respectively, of the subjects with a LRI. At age 6, physician-diagnosed asthma was present in 13.6% (OR = 3.3), 10.2% (OR = 2.4), and 4.6% of the subjects with pneumonia, LRI, and no LRI, respectively. By age 11, these values increased to 25.9% (OR = 2.8), 16.1% (OR = 1.6), and 11%, respectively. Mean maximum volume at functional residual capacity values before any LRI were lower in children with pneumonia and with LRIs than in children with no LRIs. These values continued to be lower at age 6 and by age 11, when forced expiratory volume in 1 second (FEV₁) and FEF_25–75 were recorded, similar group relationships persisted. Interestingly, despite the persistence of lowered baseline lung function in both the pneumonia and LRI groups, many of these deficits were markedly (but not completely) reduced following administration of albuterol.

In a second report, further follow-up of this large cohort of children demonstrated that the risk for both frequent (more than three episodes of wheezing per year) and infrequent (three episodes of wheezing per year) wheezing in relation to RSV lower respiratory illnesses decreased markedly with age and became nonsignificant by age 13.¹⁰⁴ These data suggest that, although RSV infections contribute substantially to the expression of the asthmatic phenotype, other factors (e.g., genetic, environmental, developmental) appear to contribute as well, either in terms of its initial expression or the modification of the phenotype over time.

CONTRIBUTION OF ATOPY

In addition to premorbid lung function, the influence of atopy on the development of the asthmatic phenotype in relationship to viral infections has also been evaluated. Interactions between these two factors appear to be bidirectional and dynamic, in that the atopic state can influence the lower airway response to viral infections, 8, 71 viral infections can influence the development of allergen sensitization, 28, 29, 99 and interactions can occur when individuals are exposed simultaneously to both allergens and viruses. 12, 68, 100

Atopy can be defined as the genetic predisposition to the preferential development of an immunoglobulin (Ig)E antibody response to a variety of environmental allergens. As stated previously, atopy has been considered to be a risk factor for the development of childhood asthma and its influence on the pattern of responses following viral infections has been of interest to many investigative groups. It has also been suggested that atopy could be a significant predisposing factor for the development of acute bronchiolitis during RSV epidemics.⁶⁴ Although some have found that children most likely to have persistent wheezing were those born to atopic parents, 64, 91, 121 others have not. 14, 73, 84 Some have found that personal atopy is not more prevalent in symptomatic children after bronchiolitis14, 73; others have found that documented RSV bronchiolitis significantly increases a child's chances (32% versus 9% in controls) of subsequently developing IgE antibody⁹⁹ or lymphocyte proliferative responses⁷⁵ to both food and aeroallergens.

RESPIRATORY SYNCYTIAL VIRUS AND THE IMMUNE RESPONSE

Respiratory syncytial virus infections may interact with immunoinflammatory mechanisms involved in immediate hypersensitivity responses in a number of ways.¹⁸ First, it has been suggested that viruses capable of infecting lower airway epithelium may lead to enhanced absorption of aeroallergens across the airway wall, predisposing to subsequent sensitization. 27, 94 Second, RSV-specific IgE antibody formation may lead to mast-cell–mediator release within the airway, resulting in the development of bronchospasm and the ingress of eosinophils. 32, 60, 85, 115, 119, 120 Third, airway resident and inflammatory cell generation of various cytokines (tumor necrosis factor [TNF], interleukin [IL]-1, IL-6, IL-8), 4, 81, 106, 109 chemokines (MIP-1-, RANTES, MCP-1), 47, 76 leukotrienes, ¹¹³ and adhesion molecules (intercellular adhesion molecule)⁸¹ may further upregulate the ongoing inflammatory response. Finally, similar to various allergenic proteins, ¹⁷ the processing of RSV antigens and their subsequent presentation to lymphocyte subpopulations may provide a unique mechanism of interaction to promote a T-helper 2 (Th2)-like response in a predisposed host.

Respiratory syncytial virus belongs to the family Paramyxoviridae, the genera Pneumovirus, and can be differentiated into two serologic subgroups, A and B. 44, 77 It has 10 genes, with 12 potential gene products. The G (attachment) and F (fusion) proteins are the major surface glycoproteins against which neutralizing antibody is directed. Interestingly, in both murine² and human⁵¹ in vitro experiments, it has been noted that the G protein elicits a predominant Th2 response, whereas the F protein produces a predominant Th1 response. In mice, to test the activities of T cells recognizing individual RSV proteins in vivo, virus-specific T-cell lines have been produced using recombinant vaccinia viruses that express either the G or F proteins. Following passive transfer of these cell lines to naive recipients and subsequent intranasal inoculation with RSV, mice receiving G-specific cells have more severe illnesses, characterized by lung hemorrhage, pulmonary neutrophil recruitment, and intense pulmonary eosinophilia.¹ These experiments are of interest based on the adverse clinical response noted in many infants who received a formalin-inactivated RSV vaccine and subsequently became infected with RSV.⁷⁷

These intriguing observations regarding RSV and its influence on Th1/Th2 responses have recently been expanded. Roman et al evaluated 15 hospitalized infants (1–15 months) with an acute lower respiratory tract infection caused by RSV. Compared with control infants, peripheral blood cells from infected children had suppressed IFN-γ production ex vivo and, although IL-4 production was also decreased, the IL-4/IFN-γ ratio was significantly increased. Renzi et al⁸⁸ prospectively followed 26 infants hospitalized with bronchiolitis by obtaining blood samples at the time of illness and 5 months later, and found that immune responses during the acute infection correlated with long-term pulmonary outcomes. Blood lymphocytes, obtained during the time of bronchiolitis, produced less IFN-γ ex vivo in response to IL-2 and more IL-4 in response to D. farinae antigen in children who went on to develop a pattern of recurrent wheezing.⁸⁸ Finally, lower IFN-γ production at the time of bronchiolitis has been demonstrated to be an indicator of reduced pulmonary function and increased responsiveness to histamine 5 months after bronchiolitis, and was related to the development of asthma after bronchiolitis in infants.⁸⁷ In contrast, other groups have noted increased levels of IFN-γ respiratory tract secretions during RSV illnesses in infants and children with bronchiolitis and recurrent wheezing compared with those with upper respiratory tract symptoms only.¹¹³ Unfortunately, in all of the studies reported thus far, the pattern of cytokine response these infants had prior to infection was not evaluated, begging the question as to which of the observed results may be cause and which effect.

ANIMAL MODELS

To more comprehensively evaluate the relationships among virus infection, atopy (cytokine dysregulation of Th1/Th2 imbalance), and immune system or lung developmental components, a rat model of virus-induced airway dysfunction has been studied extensively.¹¹¹ In this model, infection with PIV type 1 during a critical developmental time period (when the animals are weaning [3–4 weeks of age] as opposed to when they are neonates [4–5 days] or adults) produces chronic (8–12 weeks following infection), episodic, reversible airway inflammation and remodeling with associated alterations in airway physiology (increased resistance and methacholine responsiveness) that resemble human asthma in high (brown Norway strain) but not low (F344 strain) IgE-antibody producing rats.⁶² The temporal progression of this asthma-like syndrome is associated with a Th1/Th2 imbalance within the lung, and its development can be significantly attenuated by the exogenous administration of IFN-8 just prior to and during the viral infection in the brown Norway responder strain.¹⁰² This model further supports the concept of both genetic (atopy; cytokine dysregulation or imbalance) and environmental factors (virus infection) being important in the inception of the asthmatic phenotype, as well as a developmental component contributing.

EFFECT OF VIRAL INFECTIONS IN PATIENTS WITH ASTHMA

Respiratory viruses are common causes of asthma exacerbations in asthmatic subjects of different age groups. 57, 74, 86 Serology or culture detection methods of viruses initially indicated an association during asthma exacerbations⁸² despite the fact that these detection methods are relatively insensitive for viruses such as rhinovirus (RV). The use of reverse transcription polymerase chain reaction (RT-PCR) assays that are more sensitive for detection of RV have confirmed and expanded these initial observations.⁵⁸ Indeed, Johnston et al⁵⁷ found that 80% to 85% of school-aged children with acute wheezing episodes tested positive for a virus using RT-PCR and other standard virologic techniques. The virus most often detected was RV. Seasonal patterns of upper respiratory virus infections correlate closely with hospital admissions for asthma, particularly in pediatric age groups.⁵⁵ These studies indicate that RV infections are the most common cause of asthma exacerbations in children, especially during spring and fall. Similar studies, performed in adults, ⁷⁴ found that about half of asthma exacerbations were associated with RV infection.

As discussed previously, in infancy, atopy may define a susceptibility of the host to wheezing with respiratory infections. Duff et al, ²² for example, studied children who presented to an emergency department with wheezing. Children over 2 years of age were more likely to have respiratory allergies or a confirmed respiratory viral infection compared with children with no wheezing. Children with the highest risk for wheezing were those who had respiratory allergies and respiratory viral infection, implying that respiratory viral infections and respiratory allergies may have synergistic effects on lower airway physiology and enhance the likelihood of wheezing with respiratory infection. In children less than 2 years of age, wheezing was also noted, but risk factors for wheezing were quite different. These infants were not allergic, had RSV as the major viral isolate, and had passive tobacco smoke exposure as a major risk factor for wheezing.

MECHANISMS OF VIRAL-INDUCED AIRWAY OBSTRUCTION AND ASTHMA

Development of Variable Airway Obstruction

Available epidemiologic data in children and adults have shown that episodic drops in peak flow measurements are associated with RV infections. This was found to correlate with an increase in asthma symptoms and nonspecific airway hyperresponsiveness following experimentally infecting asthmatic subjects with RV. 15, 41 Further studies by Grünberg et al⁴⁰ demonstrated that experimental RV16 infection leads to a transient drop in daily home recordings of FEV₁ in subjects with asthma. This variable airway obstruction correlated significantly with cold symptoms, asthma symptoms, and the increase in airway hyperresponsiveness to histamine. Such daily variability in FEV₁ reflects the inflammatory changes within the airway wall, which can be induced by the natural RV infection.

Increased Bronchial Hyperresponsiveness

Increased bronchial responsiveness has been found in normal and asthmatic subjects following infections with RV⁶⁸ and influenza A. 65, 66, 72 In a study by Cheung et al¹⁵ 14 subjects with mild asthma were inoculated with RV16 or placebo. The maximal contractile response to inhaled methacholine was significantly greater during the RV16 infection and remained elevated for up to 15 days after the acute infection. This study indicates that an upper respiratory viral infection can enhance the reactivity of the lower airway and the magnitude of bronchonstriction changes, which can persist for weeks after the acute infection.

Respiratory viral infections' effect on lower airway responses are also influenced by host factors. In particular, allergic subjects experience greater changes in airway responsiveness after viral infection than nonallergic control subjects. 9, 34 Furthermore, subjects with lower FEV₁ values tend to have greater changes in airway responsiveness during viral infection.³⁴ These studies suggest that effects of pre-existing conditions such as allergy and intrinsic lower airway function on caliber are likely to contribute to airway hyperresponsiveness during respiratory viral infection.

Neural Control of the Airways

Potential mechanisms through which viral infections could potentially cause bronchoconstriction and increased airway responsiveness include enhancing parasympathetic bronchoconstrictive responses, stimulation of airway sensory nerves, and interference with the bronchodilatory functions of the nonadrenergic, noncholinergic neurons (Table 1) . Because of difficulties in assessing dysfunction of pulmonary neural regulation in humans, most data that support these proposed mechanisms were derived in animal models of acute respiratory viral infection. Further definition of these pathways in humans will depend upon the development of new experimental techniques or inhibition of specific neural pathways.

Table 1.

NEURAL MECHANISMS IMPLICATED IN VIRUS-INDUCED AIRWAY DYSFUNCTION

Effect of Virus	Potential Mechanisms	References
Heightened	• Increased efferent activity of efferent cholinergic nerves	Buckner et al11
parasympathetic	• Viral neuraminidase	Fryer et al30, 31
responses	• Eosinophil cationic protein-induced M2 dysfunction	Jacoby et al52
	• M2-independent mechanisms	Sorkness et al101
Bronchoconstriction	Enhanced contractile responses to neurokinins	Jacoby et al53
secondary to sensory		Ladenius et al63
C-fibers		Roberts et al89
		Saban et al93
Inhibition of nonadrenergic–noncholinergic neurons	Reduced production of nitric oxide	Colasurdo et al16

Structural Effects on the Small Airways

Changes in small airways structure and function may also contribute significantly to the severity of hyperinflation and gas exchange abnormalities noted in acute asthma exacerbations. The maximal airway contractile response to methacholine in mild asthmatic subjects is increased during a cold, which is probably secondary to excessive airway narrowing attributable to airway wall thickening, airway parenchymal uncoupling, or abnormalities in smooth muscle contraction.¹⁵ Significant changes in airway morphology are noticed in animals with acute viral respiratory illness that leads to marked bronchiolar narrowing and plugging. These changes include bronchiolar airway edema and cell infiltration, epithelial hyperplasia, and folding and sloughing of airway epithelial surfaces. In addition, rats with mild increases in pulmonary resistance and methacholine sensitivity during acute viral respiratory illness have evidence of air trapping and ventilation–perfusion mismatches.¹⁰¹ These latter findings indicate that viruses can induce significant changes in the peripheral airways that have significant functional outcomes in the absence of marked changes in measurements of airway obstruction and hyperresponsiveness.

Effects of Respiratory Viruses on Airway Inflammation

Respiratory viruses can cause inflammation and injury to healthy airways and can worsen injury in airways that are already inflamed, as demonstrable in asthma. Respiratory viruses can induce an inflammatory process by direct cytopathic effects on the airway epithelium (e.g., RSV bronchiolitis) and can induce an immune response to stop viral replication and eradicate the virus. The immune response to viral infection may be a double-edged sword, however, as virus-induced inflammation can also contribute to airway obstruction and respiratory symptoms. Indeed, although many common cold viruses (e.g., RV) do not produce significant cytopathic effects, possibly because few cells are infected, the immunoinflammatory response to the virus is probably the major cause of respiratory symptoms. In this section, the association between virus-induced immune responses and respiratory symptoms is explored.

Role of Epithelial Cells

Respiratory viruses replicate primarily in airway epithelial cells. In addition to serving as host cells, it is now well documented that epithelial cells also initiate the immune response to infections through the secretion of cytokines and chemokines. In vitro studies of epithelial cells or cell lines have demonstrated that respiratory viruses such as RV, RSV, and parainfluenzavirus can induce the secretion of many different proinflammatory cytokines (IL-1, TNF-α, GM-CSF, IL-6, IL-11) and chemokines (RANTES, IL-8, MIP-1α). 10, 20, 23, 96, 98, 105 Epithelial-derived chemokines are likely to be an important signal in initiating antiviral responses through the recruitment of leukocytes to the airway. In support of this concept, IL-8, a potent neutrophil chemoattractant, is found in high levels in nasal secretions of children with virus-induced asthma, and levels of IL-8 correlate with the number of airway neutrophils and neutrophil myeloperoxidase levels (suggesting neutrophil activation).¹⁰⁸ There is also evidence, however, that enhanced airway inflammation caused by chemokine secretion may also disturb normal airway physiology. Chemokine levels in nasal secretions correlate closely with cold symptoms, ¹¹⁰ for example, and IL-8 levels correlate with virus-induced changes in airway responsiveness.⁴¹ Levels of epithelial-derived cytokines such as IL-6 and IL-11 also correlate with respiratory symptoms, ²³ and animal studies indicate that overexpression of IL-11 can cause bronchial hyperresponsiveness. 23, 107

In addition to stimulating cytokine production, RV can upregulate epithelial cell surface expression of intercellular adhesion molecule-1, ⁷⁹ which, in addition to facilitating cell–cell adhesion, is the receptor for the major group of RV. 38, 103 This enhanced expression of adhesion proteins may contribute to the persistence and severity of inflammation in asthmatic subjects and, possibly, the greater susceptibility of asthmatic children to colds compared with nonasthmatic children.

Mechanisms for the activation of cytokine genes in epithelial cells and adhesion molecules are under investigation. It is known that nuclear factor-κ B activation is important in virus-induced transcriptional regulation of IL-6⁵⁰ and, possibly, for the synthesis of a variety of inflammatory cytokines.⁷ In addition, nitric oxide may regulate virus-induced chemokine production through a posttranscriptional mechanism and by inhibiting viral replication, ⁹⁵ although a clinical study did not find a relationship between IL-8 and nitrate levels in nasal secretions.⁵⁹

Effect on Granulocytes

Granulocyte recruitment and activation seem to have an important role in the pathogenesis of virus-induced asthma exacerbations. Grünberg et al, ⁴¹ for example, experimentally inoculated 35 atopic asthma subjects with either RV16 or placebo and found that neutrophil counts in the peripheral blood correlated with the cold and asthma symptom scores and cold-induced changes in airway hyperresponsiveness. In addition, eosinophil granular proteins and leukotriene C₄ have been detected in the nasal secretions of infants and children with virus-induced wheezing illnesses. 32, 86, 97, 116 Increased concentrations of sputum eosinophil cationic protein found during the acute phase of RV infection correlated with increases in airway responsiveness in a group of adults with asthma after experimental inoculation with RV16.³⁹ In vitro experiments indicate that RV does not activate eosinophils directly⁴⁵; it is more likely that inflammatory mediators and cytokines, secreted by virus-activated cells in the lung, contribute to eosinophil activation. Finally, guinea pigs infected with PIV develop airway eosinophils and airway hyperresponsiveness²⁵ and this outcome is blocked if the guinea pigs are pretreated with IL-5–neutralizing antibody.¹¹²

Role of Mononuclear Cells

Most respiratory viruses replicate quickly and, within a few days of inoculation, the quantity of viruses and viral proteins is sufficient to activate mononuclear cells in the airway. In vitro infection of human monocytes with respiratory viruses, for example, leads to a potent proinflammatory cytokine response by release of IL-8, IL-1, and TNF-α. 35, 54, 90 Interleukin-1 and TNF-α can increase cell recruitment into the airway by enhancing adhesion molecule expression on endothelial cells. In addition, TNF-α has been associated with wheezing illnesses in infancy⁶ and the development of late-phase allergic reaction and asthma. 3, 37 Monocytes and macrophages also produce interferon (INF), and its appearance in nasal secretions coincides with the onset of the recovery process. In addition to cytokine production, macrophages incubated with RSV or PIV produce lipid mediators such as prostaglandin E₂, platelet-activating factor, and thromboxane B₂ 48, 78, 114 that can augment airway inflammation.

Lymphocytes, including natural killer cells, CD8+ cytotoxic T cells, and CD4+ T cells, are involved in limiting viral replication and viral clearance. To test the possibility that variations in lymphocyte responses might account for variability in the ability to clear viral infections, Parry et al⁸⁰ measured in vitro lymphocyte responses in a group of allergic subjects who were then inoculated with RV 16. Vigorous virus-induced responses (lymphocyte proliferation or IFN-γ secretion) before inoculation correlated with reduced viral shedding after inoculation. These results suggest that factors related to the host cellular response help determine the degree of viral replication during respiratory viral infections. Further characterization of these host factors may lead to new therapeutic strategies for respiratory infections, a goal that is particularly important for people with asthma.

Several studies have shown that viral infections activate a wide range of T cells. Evidence for this comes from experiments in mice, in which most of the T cells found in the lung after an acute viral infection are not virus-specific, ²¹ and in vitro studies, in which 25% to 50% of human peripheral blood T cells express the early activation marker CD69 after 24 hours in culture with RV.³⁶ RANTES, induced by respiratory viruses, at high concentrations can also induce antigen-independent T-cell activation.⁵ These studies suggest that respiratory viruses can induce early, nonspecific T-cell activation and recruitment that could significantly increase the intensity of airway inflammation, resulting in airway dysfunction and respiratory symptoms.

This hypothesis is supported by studies of volunteers infected with rhinovirus. Respiratory virus infections usually cause peripheral lymphopenia and increased numbers of lymphocytes in the upper and lower airways, for example. The degree of peripheral blood lymphopenia and lymphocytic infiltration of the airway epithelium has been correlated with the increases in airway responsiveness. 15, 26

Interactions Between Viral Infections and Responses to Allergen

Although viral infections cause similar upper respiratory symptoms in allergic and nonallergic individuals, 46, 100 there is evidence of interactions between virus- and allergen-induced responses in the lower airway. Lemanske and colleagues, ⁶⁹ for example, identified 10 patients with allergic rhinitis and experimentally infected them with RV16. The viral infection increased airway reactivity to both inhaled allergen and histamine, and also increased the frequency of a late allergic reaction to inhaled antigens. Moreover, Calhoun and colleagues¹³ used bronchoscopy to study the inflammatory response to allergen in individual lung segments before, during, and 1 month after RV16 infection. RV infection enhanced the immediate antigen-induced release of histamine, and also increased eosinophil recruitment of eosinophils to the lung.

SUMMARY

Respiratory infections can have dual effects related to asthma. First, there is increasing evidence that severe infections with RSV and PIV in infancy can alter lung development and physiology to increase the risks of subsequent wheezing and asthma. Second, infections with common cold viruses and influenza commonly precipitate wheezing symptoms in children and adults who already have established asthma, and RV appears to be the most important virus in producing exacerbations of the disease. The principal mechanisms by which this occurs appears to be viral replication in epithelial cells, triggering a cascade of inflammation involving granulocytes, macrophages, T cells, and secreted cytokines and mediators. The inflammatory process, although essential to clear the infection, augments pre-existing airway inflammation in asthma, leading to increased airway obstruction and lower respiratory tract symptoms. Greater understanding of virus-induced changes in inflammation and corresponding changes in airway physiology may lead to new therapeutic approaches to the treatment and prevention of virus-induced airway dysfunction.